HAE insider transactions
Haemonetics Corporation (HAE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for HAE
- VP, Chief Accounting Officer Maunsell Farris Maryanne covered exercise/tax liability with 259 shares, decreasing direct ownership by 4% to 6,242 units (SEC Form 4) (tax withholding)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. covered exercise/tax liability with 313 shares, decreasing direct ownership by 0.76% to 40,987 units (SEC Form 4) (for withholding tax)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP and General Counsel Basil Michelle L covered exercise/tax liability with 2,913 shares and was granted 28,424 shares, increasing direct ownership by 59% to 68,829 units (SEC Form 4) (tax withholding)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Operating Officer Chan Frank was granted 27,535 shares and covered exercise/tax liability with 546 shares, increasing direct ownership by 454% to 32,936 units (SEC Form 4) (tax withholding)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James covered exercise/tax liability with 2,505 shares and was granted 29,312 shares, increasing direct ownership by 97% to 54,444 units (SEC Form 4) (for withholding tax)4 - HAEMONETICS CORP (0000313143) (Issuer)
- VP, Chief Accounting Officer Maunsell Farris Maryanne covered exercise/tax liability with 197 shares and was granted 2,220 shares, increasing direct ownership by 45% to 6,501 units (SEC Form 4) to cover taxes4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Commercial Officer Galvin Roy covered exercise/tax liability with 879 shares and was granted 27,535 shares, increasing direct ownership by 202% to 39,882 units (SEC Form 4) to satisfy withholding tax4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. covered exercise/tax liability with 948 shares and was granted 13,323 shares, increasing direct ownership by 43% to 41,300 units (SEC Form 4) to cover withholding tax4 - HAEMONETICS CORP (0000313143) (Issuer)
- President & CEO Simon, Christopher covered exercise/tax liability with 9,681 shares and was granted 78,344 shares, increasing direct ownership by 18% to 444,704 units (SEC Form 4) (withholding obligation)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James covered exercise/tax liability with 655 shares, decreasing direct ownership by 2% to 27,637 units (SEC Form 4) (withholding tax)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Kroll Mark W bought $98,784 worth of shares (1,400 units at $70.56), increasing direct ownership by 6% to 24,757 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Commercial Officer Galvin Roy covered exercise/tax liability with 145 shares, decreasing direct ownership by 1% to 12,811 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.82% to 28,925 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Zane Ellen M was granted 2,693 shares, increasing direct ownership by 16% to 19,373 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Pomeroy Claire was granted 2,693 shares, increasing direct ownership by 19% to 16,872 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Kroll Mark W was granted 2,693 shares, increasing direct ownership by 13% to 23,357 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Johnson Lloyd Emerson was granted 2,693 shares, increasing direct ownership by 26% to 12,933 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Dockendorff Charles J was granted 2,693 shares, increasing direct ownership by 61% to 7,126 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Coyle Michael J was granted 2,693 shares, increasing direct ownership by 21% to 15,394 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Bryant Diane M was granted 2,693 shares, increasing direct ownership by 61% to 7,126 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Abernathy Robert E was granted 2,693 shares, increasing direct ownership by 12% to 24,981 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Amendment: EVP and General Counsel Basil Michelle L was granted 6,755 shares, increasing direct ownership by 24% to 35,233 units (SEC Form 4)4/A - HAEMONETICS CORP (0000313143) (Issuer)
- Amendment: EVP, Chief Commercial Officer Galvin Roy was granted 5,689 shares, increasing direct ownership by 79% to 12,932 units (SEC Form 4)4/A - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. was granted 3,195 shares, increasing direct ownership by 12% to 29,163 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- VP, Chief Accounting Officer Maunsell Farris Maryanne was granted 2,662 shares, increasing direct ownership by 147% to 4,478 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President & CEO Simon, Christopher was granted 66,666 shares and covered exercise/tax liability with 26,234 shares, increasing direct ownership by 12% to 375,544 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. was granted 7,777 shares and covered exercise/tax liability with 2,283 shares, increasing direct ownership by 27% to 25,968 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James was granted 12,221 shares and covered exercise/tax liability with 5,864 shares, increasing direct ownership by 29% to 28,292 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP and General Counsel Basil Michelle L was granted 15,554 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 24% to 42,252 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- VP, Chief Accounting Officer Maunsell Farris Maryanne was granted 800 shares, increasing direct ownership by 79% to 1,816 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. was granted 3,200 shares, increasing direct ownership by 19% to 20,474 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Operating Officer Chan Frank was granted 5,689 shares (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President, Global Plasma & BC Galvin Roy was granted 6,755 shares, increasing direct ownership by 93% to 13,998 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP and General Counsel Basil Michelle L was granted 5,689 shares, increasing direct ownership by 20% to 34,167 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James was granted 7,111 shares, increasing direct ownership by 48% to 21,935 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President & CEO Simon, Christopher was granted 21,405 shares, increasing direct ownership by 7% to 335,112 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP and General Counsel Basil Michelle L covered exercise/tax liability with 2,779 shares, decreasing direct ownership by 9% to 28,478 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James covered exercise/tax liability with 1,868 shares, decreasing direct ownership by 11% to 14,824 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- VP, Chief Accounting Officer Maunsell Farris Maryanne covered exercise/tax liability with 128 shares, decreasing direct ownership by 11% to 1,016 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President, Global Plasma & BC Galvin Roy covered exercise/tax liability with 458 shares, decreasing direct ownership by 6% to 7,243 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. covered exercise/tax liability with 683 shares, decreasing direct ownership by 4% to 17,274 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President & CEO Simon, Christopher covered exercise/tax liability with 9,480 shares, decreasing direct ownership by 3% to 313,707 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Financial Officer Darecca James covered exercise/tax liability with 654 shares, decreasing direct ownership by 4% to 16,692 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SEC Form 3 filed by new insider Chan Frank3 - HAEMONETICS CORP (0000313143) (Issuer)
- President, Global Plasma & BC Galvin Roy covered exercise/tax liability with 161 shares, decreasing direct ownership by 2% to 7,373 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- SVP, Human Resources Miller Laurie A. covered exercise/tax liability with 238 shares, decreasing direct ownership by 1% to 17,807 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President & CEO Simon, Christopher disposed of $3,000,034 worth of shares (39,704 units at $75.56), decreasing direct ownership by 11% to 322,838 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President, Global Hospital Strong Stewart W sold $393,039 worth of shares (4,312 units at $91.15), decreasing direct ownership by 19% to 18,196 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- President, Global Hospital Strong Stewart W was granted 7,110 shares and covered exercise/tax liability with 2,798 shares, increasing direct ownership by 24% to 22,508 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Abernathy Robert E was granted 2,207 shares, increasing direct ownership by 11% to 22,288 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Bryant Diane M was granted 2,207 shares, increasing direct ownership by 99% to 4,433 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Coyle Michael J was granted 2,207 shares, increasing direct ownership by 21% to 12,701 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Dockendorff Charles J was granted 2,207 shares, increasing direct ownership by 99% to 4,433 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Johnson Lloyd Emerson was granted 2,207 shares, increasing direct ownership by 27% to 10,240 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Kroll Mark W was granted 2,207 shares, increasing direct ownership by 12% to 20,664 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Pomeroy Claire was granted 2,207 shares, increasing direct ownership by 18% to 14,179 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Director Zane Ellen M was granted 2,207 shares, increasing direct ownership by 15% to 16,680 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- EVP, Chief Technology Officer Lingamneni Anila sold $199,350 worth of shares (2,215 units at $90.00), decreasing direct ownership by 9% to 21,331 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Simon, Christopher exercised 104,516 shares at a strike of $41.64 and covered exercise/tax liability with 71,335 shares, increasing direct ownership by 10% to 362,542 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)
- Lingamneni Anila was granted 14,140 shares and covered exercise/tax liability with 5,279 shares, increasing direct ownership by 60% to 23,546 units (SEC Form 4)4 - HAEMONETICS CORP (0000313143) (Issuer)